Habitual intake of dietary flavonoids and risk of Parkinson disease
- PMID: 22491871
- PMCID: PMC3320056
- DOI: 10.1212/WNL.0b013e31824f7fc4
Habitual intake of dietary flavonoids and risk of Parkinson disease
Abstract
Objective: To prospectively examine whether higher intakes of total flavonoids and their subclasses (flavanones, anthocyanins, flavan-3-ols, flavonols, flavones, and polymers) were associated with a lower risk of developing Parkinson disease (PD).
Methods: In the current analysis, we included 49,281 men in the Health Professional Follow-up Study and 80,336 women from the Nurses' Health Study. Five major sources of flavonoid-rich foods (tea, berry fruits, apples, red wine, and orange/orange juice) were also examined. Flavonoid intake was assessed using an updated food composition database and a validated food frequency questionnaire.
Results: We identified 805 participants (438 men and 367 women) who developed PD during 20-22 years of follow-up. In men, after adjusting for multiple confounders, participants in the highest quintile of total flavonoids had a 40%lower PD risk than those in the lowest quintile (hazard ratio [HR] = 0.60; 95% confidence interval 0.43, 0.83; p trend = 0.001). No significant relationship was observed in women (p trend = 0.62) or in pooled analyses (p trend = 0.23). In the pooled analyses for the subclasses, intakes of anthocyanins and a rich dietary source, berries, were significantly associated with a lower PD risk (HR comparing 2 extreme intake quintiles were 0.76 for anthocyanins and 0.77 for berries, respectively; p trend < 0.02 for both).
Conclusions: Our findings suggest that intake of some flavonoids may reduce PD risk, particularly in men, but a protective effect of other constituents of plant foods cannot be excluded.
Comment in
-
An apple a day to prevent Parkinson disease: reduction of risk by flavonoids.Neurology. 2012 Apr 10;78(15):1112-3. doi: 10.1212/WNL.0b013e31824f80e4. Epub 2012 Apr 4. Neurology. 2012. PMID: 22491859 No abstract available.
References
-
- Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004; 79: 727– 747 - PubMed
-
- Waterhouse AL, Shirley JR, Donovan JL. Antioxidants in chocolate. Lancet 1996; 348: 834 - PubMed
-
- Kroon PA, Clifford MN, Crozier A, et al. How should we assess the effects of exposure to dietary polyphenols in vitro? Am J Clin Nutr 2004; 80: 15– 21 - PubMed
-
- Spencer JP. Flavonoids: modulators of brain function? Br J Nutr 2008; 99 (E Suppl 1): ES60– E77 - PubMed
-
- Ramassamy C. Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur J Pharmacol 2006; 545: 51– 64 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical